DrugPatentWatch Database Preview
Boscogen Company Profile
What is the competitive landscape for BOSCOGEN, and what generic and branded alternatives to BOSCOGEN drugs are available?
BOSCOGEN has five approved drugs.
Summary for Boscogen
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Boscogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boscogen | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-005 | Jan 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-003 | Jan 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-002 | Apr 24, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-006 | Jan 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Boscogen | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-002 | Jan 9, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
